Bone Marrow Transplantation - Table of Contents alert Volume 50 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 50, Issue 5 (May 2015) In this issue Editorial Reviews Special Report Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients N A Berger Bone Marrow Transplant 2015 50: 617-618; advance online publication, March 2, 2015; 10.1038/bmt.2015.26 Full Text Reviews Top Alternative donor transplant of benign primary hematologic disorders J Tolar, P Sodani and H Symons Bone Marrow Transplant 2015 50: 619-627; advance online publication, February 9, 2015; 10.1038/bmt.2015.1 Abstract | Full Text Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? R Tamari, T I Mughal, D Rondelli, R Hasserjian, V Gupta, O Odenike, V Fauble, G Finazzi, F Pane, J Mascarenhas, J Prchal, S Giralt and R Hoffman Bone Marrow Transplant 2015 50: 628-636; advance online publication, February 9, 2015; 10.1038/bmt.2014.323 Abstract | Full Text Special Report Top Related hematopoietic cell donor care: is there a role for unrelated donor registries? C Anthias, S M van Walraven, B S Sørensen, G N de Faveri, M Fechter, J Cornish, A Bacigalupo, C Müller, M Boo and B E Shaw Bone Marrow Transplant 2015 50: 637-641; advance online publication, March 2, 2015; 10.1038/bmt.2015.15 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA A multigene array for measurable residual disease detection in AML patients undergoing SCT OPEN M Goswami, K S McGowan, K Lu, N Jain, J Candia, N F Hensel, J Tang, K R Calvo, M Battiwalla, A J Barrett and C S Hourigan Bone Marrow Transplant 2015 50: 642-651; advance online publication, February 9, 2015; 10.1038/bmt.2014.326 Abstract | Full Text LYMPHOMA Outcomes after autologous SCT in lymphoma patients grouped by weight J E Lau, C Weber, M Earl, L A Rybicki, K D Carlstrom, C M Wenzell, B T Hill, N S Majhail and M Kalaycio Bone Marrow Transplant 2015 50: 652-657; advance online publication, February 9, 2015; 10.1038/bmt.2014.327 Abstract | Full Text PLASMA CELL DISORDERS Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution L Rosiñol, R Jiménez, M Rovira, C Martínez, F Fernández-Avilés, P Marín, M Suárez-Lledó, G Gutiérrez-García, C Fernández de Larrea, E Carreras, A Urbano-Ispizua and J Bladé Bone Marrow Transplant 2015 50: 658-662; advance online publication, January 26, 2015; 10.1038/bmt.2014.320 Abstract | Full Text Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy C Phipps, M Linenberger, L A Holmberg, D Green, P Becker, L Connelly-Smith, Z Klippel, N Burwick, A Gopal, W I Bensinger and E Libby Bone Marrow Transplant 2015 50: 663-667; advance online publication, March 2, 2015; 10.1038/bmt.2015.13 Abstract | Full Text High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis P Kongtim, M H Qazilbash, J J Shah, A Hamdi, N Shah, Q Bashir, M Wang, R Champlin, E E Manasanch, D Weber, R Z Orlowski and S Parmar Bone Marrow Transplant 2015 50: 668-672; advance online publication, March 2, 2015; 10.1038/bmt.2015.21 Abstract | Full Text HEMATOPOIETIC CELL COLLECTION Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation A Brioli, G Perrone, F Patriarca, A Pezzi, F Nobile, F Ballerini, M R Motta, S Ronconi, P Tacchetti, L Catalano, B A Zannetti, S Rizzi, S Volpe, E Zamagni, A M Liberati, K Mancuso, M Boccadoro, F E Davies, G J Morgan, A Palumbo and M Cavo Bone Marrow Transplant 2015 50: 673-678; advance online publication, February 2, 2015; 10.1038/bmt.2014.322 Abstract | Full Text GRAFT SOURCE Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma A-K Zoellner, S Fritsch, D Prevalsek, N Engel, M Hubmann, R Reibke, C T Rieger, J C Hellmuth, M Haas, F Mumm, T Herold, G Ledderose, W Hiddemann, M Dreyling, A Hausmann and J Tischer Bone Marrow Transplant 2015 50: 679-684; advance online publication, February 2, 2015; 10.1038/bmt.2014.328 Abstract | Full Text Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study I Esteves, C Bonfim, R Pasquini, V Funke, N F Pereira, V Rocha, Y Novis, C Arrais, V Colturato, M P de Souza, M Torres, J F Fernandes, F R Kerbauy, A A F Ribeiro, F P S Santos and N Hamerschlak Bone Marrow Transplant 2015 50: 685-689; advance online publication, March 2, 2015; 10.1038/bmt.2015.20 Abstract | Full Text CELLULAR THERAPY 5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft J Steinmann, H Bertz, R Wäsch, R Marks, R Zeiser, L Bogatyreva, J Finke and M Lübbert Bone Marrow Transplant 2015 50: 690-695; advance online publication, March 16, 2015; 10.1038/bmt.2015.10 Abstract | Full Text CONDITIONING Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients J Yin, Y Xiao, H Zheng and Y C Zhang Bone Marrow Transplant 2015 50: 696-705; advance online publication, March 2, 2015; 10.1038/bmt.2015.14 Abstract | Full Text TRANSPLANT TOXICITIES Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis I Vaxman, R Ram, A Gafter-Gvili, L Vidal, M Yeshurun, M Lahav and O Shpilberg Bone Marrow Transplant 2015 50: 706-714; advance online publication, February 9, 2015; 10.1038/bmt.2014.325 Abstract | Full Text Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation S R Hingorani, K Seidel, E Pao, R Lawler and G B McDonald Bone Marrow Transplant 2015 50: 715-720; advance online publication, February 9, 2015; 10.1038/bmt.2015.2 Abstract | Full Text Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT J D Pole, D Darmawikarta, A Gassas, M Ali, M Egler, M L Greenberg, J Doyle, P C Nathan and T Schechter Bone Marrow Transplant 2015 50: 721-726; advance online publication, February 23, 2015; 10.1038/bmt.2015.4 Abstract | Full Text Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy M Tanaka, H Kanamori, K Matsumoto, T Tachibana, A Numata, K Ohashi, T Kobayashi, C Nakaseko, Y Kanda, E Yamazaki, S Fujisawa, J Ooi, T Sakura, N Aotsuka, M Onoda, S Machida, J Kato, K Usuki, R Watanabe, J Taguchi, S Yano, T Saito, S Takahashi, H Sakamaki, S Okamoto and Kanto Study Group for Cell Therapy Bone Marrow Transplant 2015 50: 727-733; advance online publication, March 2, 2015; 10.1038/bmt.2015.17 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD N Alam, W Xu, E G Atenafu, J Uhm, M Seftel, V Gupta, J Kuruvilla, J H Lipton, H A Messner and D D H Kim Bone Marrow Transplant 2015 50: 734-742; advance online publication, March 16, 2015; 10.1038/bmt.2015.19 Abstract | Full Text Letters to the Editor Top Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT L Eggimann, S Girsberger, J Halter, S Gerull, A Tichelli, H Baldomero, D Heim, J Passweg and A Rovó Bone Marrow Transplant 2015 50: 743-745; advance online publication, March 2, 2015; 10.1038/bmt.2015.3 Full Text Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome I Aldoss, A Dagis, J Palmer, S Forman and V Pullarkat Bone Marrow Transplant 2015 50: 746-748; advance online publication, March 2, 2015; 10.1038/bmt.2015.8 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.